
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Structural changes in the SARS-CoV-2 spike E406W mutant escaping a clinical monoclonal antibody cocktail
Amin Addetia, Young‐Jun Park, Tyler N. Starr, et al.
Cell Reports (2023) Vol. 42, Iss. 6, pp. 112621-112621
Open Access | Times Cited: 19
Amin Addetia, Young‐Jun Park, Tyler N. Starr, et al.
Cell Reports (2023) Vol. 42, Iss. 6, pp. 112621-112621
Open Access | Times Cited: 19
Showing 19 citing articles:
SARS-CoV-2 variant evasion of monoclonal antibodies based on in vitro studies
MacGregor Cox, Thomas P. Peacock, William T. Harvey, et al.
Nature Reviews Microbiology (2022) Vol. 21, Iss. 2, pp. 112-124
Open Access | Times Cited: 272
MacGregor Cox, Thomas P. Peacock, William T. Harvey, et al.
Nature Reviews Microbiology (2022) Vol. 21, Iss. 2, pp. 112-124
Open Access | Times Cited: 272
Shifting mutational constraints in the SARS-CoV-2 receptor-binding domain during viral evolution
Tyler N. Starr, Allison J. Greaney, William W. Hannon, et al.
Science (2022) Vol. 377, Iss. 6604, pp. 420-424
Open Access | Times Cited: 248
Tyler N. Starr, Allison J. Greaney, William W. Hannon, et al.
Science (2022) Vol. 377, Iss. 6604, pp. 420-424
Open Access | Times Cited: 248
Monoclonal antibody therapies against SARS-CoV-2
Daniele Focosi, Scott A. McConnell, Arturo Casadevall, et al.
The Lancet Infectious Diseases (2022) Vol. 22, Iss. 11, pp. e311-e326
Open Access | Times Cited: 214
Daniele Focosi, Scott A. McConnell, Arturo Casadevall, et al.
The Lancet Infectious Diseases (2022) Vol. 22, Iss. 11, pp. e311-e326
Open Access | Times Cited: 214
A Critical Analysis of the Use of Cilgavimab plus Tixagevimab Monoclonal Antibody Cocktail (Evusheld™) for COVID-19 Prophylaxis and Treatment
Daniele Focosi, Arturo Casadevall
Viruses (2022) Vol. 14, Iss. 9, pp. 1999-1999
Open Access | Times Cited: 52
Daniele Focosi, Arturo Casadevall
Viruses (2022) Vol. 14, Iss. 9, pp. 1999-1999
Open Access | Times Cited: 52
In search of a pan-coronavirus vaccine: next-generation vaccine design and immune mechanisms
S. Cankat, M. U. Demael, Leo Swadling
Cellular and Molecular Immunology (2023) Vol. 21, Iss. 2, pp. 103-118
Open Access | Times Cited: 31
S. Cankat, M. U. Demael, Leo Swadling
Cellular and Molecular Immunology (2023) Vol. 21, Iss. 2, pp. 103-118
Open Access | Times Cited: 31
Antigenic mapping and functional characterization of human New World hantavirus neutralizing antibodies
Taylor B. Engdahl, Elad Binshtein, Rebecca L. Brocato, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 19
Taylor B. Engdahl, Elad Binshtein, Rebecca L. Brocato, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 19
Mapping immunodominant sites on the MERS-CoV spike glycoprotein targeted by infection-elicited antibodies in humans
Amin Addetia, Cameron Stewart, Albert J. Seo, et al.
Cell Reports (2024) Vol. 43, Iss. 8, pp. 114530-114530
Open Access | Times Cited: 8
Amin Addetia, Cameron Stewart, Albert J. Seo, et al.
Cell Reports (2024) Vol. 43, Iss. 8, pp. 114530-114530
Open Access | Times Cited: 8
Mapping immunodominant sites on the MERS-CoV spike glycoprotein targeted by infection-elicited antibodies in humans
Amin Addetia, Cameron Stewart, Albert J. Seo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 5
Amin Addetia, Cameron Stewart, Albert J. Seo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 5
SARS-CoV-2 Monoclonal Antibody Treatment Followed by Vaccination Shifts Human Memory B-Cell Epitope Recognition, Suggesting Antibody Feedback
Nathaniel I. Bloom, Sydney I. Ramirez, Hallie Cohn, et al.
The Journal of Infectious Diseases (2024) Vol. 230, Iss. 5, pp. 1187-1196
Open Access | Times Cited: 5
Nathaniel I. Bloom, Sydney I. Ramirez, Hallie Cohn, et al.
The Journal of Infectious Diseases (2024) Vol. 230, Iss. 5, pp. 1187-1196
Open Access | Times Cited: 5
A structural dynamic explanation for observed escape of SARS-CoV-2 BA.2 variant mutation S371L/F
Nathaniel L. Miller, Thomas A. Clark, Rahul Raman, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 11
Nathaniel L. Miller, Thomas A. Clark, Rahul Raman, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 11
Complexity of Viral Epitope Surfaces as Evasive Targets for Vaccines and Therapeutic Antibodies
Nathaniel L. Miller, Rahul Raman, Thomas A. Clark, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 10
Nathaniel L. Miller, Rahul Raman, Thomas A. Clark, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 10
Research Progress on Spike-Dependent SARS CoV-2 Fusion Inhibitors and Small Molecules Targeting the S2 Subunit of Spike
Matthew R. Freidel, Roger S. Armen
(2024)
Open Access | Times Cited: 1
Matthew R. Freidel, Roger S. Armen
(2024)
Open Access | Times Cited: 1
Research Progress on Spike-Dependent SARS-CoV-2 Fusion Inhibitors and Small Molecules Targeting the S2 Subunit of Spike
Matthew R. Freidel, Roger S. Armen
Viruses (2024) Vol. 16, Iss. 5, pp. 712-712
Open Access | Times Cited: 1
Matthew R. Freidel, Roger S. Armen
Viruses (2024) Vol. 16, Iss. 5, pp. 712-712
Open Access | Times Cited: 1
SARS-CoV-2 monoclonal antibody treatment followed by vaccination shifts human memory B cell epitope recognition suggesting antibody feedback
Camila H. Coelho, Nathaniel I. Bloom, Sydney I. Ramirez, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
Camila H. Coelho, Nathaniel I. Bloom, Sydney I. Ramirez, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
Causes and Consequences of Coronavirus Spike Protein Variability
Fabian Zech, Christoph Jung, Timo Jacob, et al.
Viruses (2024) Vol. 16, Iss. 2, pp. 177-177
Open Access
Fabian Zech, Christoph Jung, Timo Jacob, et al.
Viruses (2024) Vol. 16, Iss. 2, pp. 177-177
Open Access
Prospects of Innovative Therapeutics in Combating the COVID-19 Pandemic
Thamby Rajah Mahendran, Binsin Cynthia, Ramesh Thevendran, et al.
Molecular Biotechnology (2024)
Closed Access
Thamby Rajah Mahendran, Binsin Cynthia, Ramesh Thevendran, et al.
Molecular Biotechnology (2024)
Closed Access
The ratio between SARS-CoV-2 RNA viral load and culturable viral titer differs depending on stage of infection
Michael K. Porter, Alexander Viloria Winnett, Linhui Hao, et al.
(2023)
Open Access
Michael K. Porter, Alexander Viloria Winnett, Linhui Hao, et al.
(2023)
Open Access